Brokerages Set Haleon plc (LON:HLN) Price Target at GBX 398.67

Haleon plc (LON:HLN) has earned a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is GBX 395.33.

HLN has been the topic of several analyst reports. JPMorgan Chase & Co. decreased their price objective on Haleon from GBX 335 to GBX 315 and set an “underweight” rating on the stock in a report on Thursday. Berenberg Bank restated a “buy” rating and set a GBX 512 price objective on shares of Haleon in a report on Thursday, April 30th. Jefferies Financial Group decreased their price objective on Haleon from GBX 450 to GBX 400 and set a “buy” rating on the stock in a report on Tuesday, May 5th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and set a GBX 370 price target on shares of Haleon in a research note on Thursday, April 30th.

Haleon Price Performance

HLN stock opened at GBX 348.80 on Friday. Haleon has a 52-week low of GBX 317.80 and a 52-week high of GBX 416.10. The stock’s fifty day simple moving average is GBX 338.64 and its 200-day simple moving average is GBX 364.03. The company has a quick ratio of 0.93, a current ratio of 0.92 and a debt-to-equity ratio of 52.26. The stock has a market capitalization of £30.86 billion, a price-to-earnings ratio of 18.85, a price-to-earnings-growth ratio of 1.49 and a beta of 0.25.

Haleon Company Profile

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s product portfolio spans six major categories – Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands – such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren – are built on trusted science, innovation and deep human understanding.